Intrapleural streptokinase treatment in children with empyema.
Our aim was to compare intrapleural streptokinase (SK) treatment and simple tube drainage in the treatment of children with complicated parapneumonic pleural effusion. A retrospective review of medical records included patient demographics, clinical presentation, biochemical and microbial studies of pleural effusion, radiographic evaluation of chest tube drainage, use of fibrinolytic agents and type of surgical intervention. During the 2.5-year period (1999-2002), 53 children (29 M, 24 F) with complicated parapneumonic effusions or empyema were identified. Closed tube drainage and antibiotic treatment were administered to patients with a diagnosis of complicated parapneumonic effusion (n = 24) until October 2000; after that time point, intrapleural streptokinase was added to this regimen (n = 29). The median age at the time of presentation was 2.5 years (range: 5 months-14.6 years). There were no significant differences in terms of clinical outcomes between the two groups. The average length of hospital stay was 19.1 +/- 5.5 and 21.9 +/- 11.2 days for the drainage and streptokinase groups, respectively; the time to afebrile state after admission was 5.8 +/- 4.1 and 7.6 +/- 7.5 days. The percentage of patients who eventually required surgical intervention was 8.3% for the drainage group and 20.6% for the streptokinase group. In conclusion, in the treatment of complicated parapneumonic effusions or empyema, the adjunctive treatment with intrapleural SK does not significantly reduce durations of fever, chest tube drainage and hospital stay, and the need for surgery, regardless of the stage of the disease, compared to simple closed tube drainage.
Aydoğan
Metin
M
Department of Pediatric Allergy, School of Medicine, Kocaeli University, Kocaeli, Turkey. mmetinaydogan@hotmail.com
Aydoğan
Ayşen
A
Ozcan
Ayla
A
Tugay
Melih
M
Gokalp
Ayse Sevim
AS
Arisoy
Emin Sami
ES
D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D017714:Community-Acquired Infections / Q000188:drug therapy; D004322:Drainage; D016724:Empyema, Pleural / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D017052:Hospital Mortality; D006801:Humans; D007223:Infant; D007902:Length of Stay; D008297:Male; D008499:Medical Records; D011014:Pneumonia / Q000150:complications / Q000188:drug therapy*; D012189:Retrospective Studies; D013300:Streptokinase / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D005343:Fibrinolytic Agents; D013300:Streptokinase
Chest. 1993 Apr;103(4):1190-3
8131463
Arch Dis Child. 2003 Oct;88(10):915-7
14500314
Chest. 1995 Jun;107(6):1532-7
7781342
Pediatrics. 2005 Jun;115(6):1652-9
15930229
Thorax. 2002 Apr;57(4):343-7
11923554
Chest. 2000 Oct;118(4):1158-71
11035692
Acta Paediatr. 2000 Apr;89(4):417-20
10830452
Chest. 1997 Dec;112(6):1579-83
9404757
Am J Respir Crit Care Med. 2004 Jul 1;170(1):49-53
15044206
Pediatr Pulmonol. 2003 Jan;35(1):50-5
12461739
Am J Med. 1980 Oct;69(4):507-12
7424940
N Engl J Med. 2005 Mar 3;352(9):865-74
15745977
J Clin Invest. 1949 Jan;28(1):173-90
16695653
Ann Thorac Surg. 2003 Dec;76(6):1849-53; discussion 1853
14667597
Thorax. 1997 May;52(5):416-21
9176531
Am J Respir Crit Care Med. 1999 Jan;159(1):37-42
9872815
Int J Clin Pract. 2001 Dec;55(10):658-60
11777287
Cochrane Database Syst Rev. 2004;(2):CD002312
15106174
J Pediatr Surg. 1997 Oct;32(10):1473-5
9349773
Chest. 2004 Feb;125(2):566-71
14769739
Pediatr Pulmonol. 2005 Feb;39(2):127-34
15573391
Thorax. 2003 May;58 Suppl 2:ii18-28
12728147
Pediatr Surg Int. 2004 Jul;20(7):520-4
15185109
Am J Respir Crit Care Med. 1997 Jan;155(1):291-5
9001327
Pediatr Surg Int. 2002 Jan;18(1):21-3
11793057